Shanghai Rendu Biotechnology Co. Ltd. A (688193) — Capital Reinvestment Ratio
Shanghai Rendu Biotechnology Co. Ltd. A (688193) has a Capital Reinvestment Ratio of 0.32x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥22.41 Million) in capital expenditures (CN¥7.07 Million). See Shanghai Rendu Biotechnology Co. Ltd. A net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Rendu Biotechnology Co. Ltd. A Capital Reinvestment Ratio (2019–2025)
This chart tracks Shanghai Rendu Biotechnology Co. Ltd. A's Capital Reinvestment Ratio across 6 annual periods. Check Shanghai Rendu Biotechnology Co. Ltd. A total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shanghai Rendu Biotechnology Co. Ltd. A (2019–2025)
Year-by-year Capital Reinvestment Ratio for Shanghai Rendu Biotechnology Co. Ltd. A from 2019 to 2025. For live market cap and broader valuation context, see Shanghai Rendu Biotechnology Co. Ltd. A (688193) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.32x | CN¥22.41 Million | CN¥7.07 Million | ▼ -26.8% |
| 2024 | 0.43x | CN¥24.39 Million | CN¥10.52 Million | ▼ -63.6% |
| 2023 | 1.19x | CN¥17.19 Million | CN¥20.39 Million | ▲ +143.9% |
| 2021 | 0.49x | CN¥54.44 Million | CN¥26.48 Million | ▲ +189.7% |
| 2020 | 0.17x | CN¥92.61 Million | CN¥15.55 Million | ▼ -95.8% |
| 2019 | 4.01x | CN¥13.67 Million | CN¥54.83 Million | — |